相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery, Function, and Therapeutic Targeting of Siglec-8
Bradford A. Youngblood et al.
CELLS (2021)
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies
Elizabeth A. Jacobsen et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
Contributions of Eosinophils to Human Health and Disease
Amy D. Klion et al.
Annual Review of Pathology-Mechanisms of Disease (2020)
Multiple Biological Aspects of Eosinophils in Host Defense, Eosinophil-Associated Diseases, Immunoregulation, and Homeostasis: Is Their Role Beneficial, Detrimental, Regulator, or Bystander?
Akira Kanda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2020)
Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia An ACLPS Critical Review
Daiva M. Mattis et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
Emma K. Persson et al.
SCIENCE (2019)
Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options
Paneez Khoury et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Eosinophils: Old Players in a New Game
B. Sastre et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2018)
Hypereosinophilic syndrome: approach to treatment in the era of precision medicine
Amy Klion
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Functions of tissue-resident eosinophils
Peter F. Weller et al.
NATURE REVIEWS IMMUNOLOGY (2017)
World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management
Jason Gotlib
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Hypereosinophilic Syndrome
Casey Curtis et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
RhoH is a negative regulator of eosinophilopoiesis
Christina Stoeckle et al.
CELL DEATH AND DIFFERENTIATION (2016)
Novel Targeted Therapies for Eosinophil-Associated Diseases and Allergy
Susanne Radonjic-Hoesli et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Spectrum of Eosinophilic End-Organ Manifestations
Praveen Akuthota et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2015)
Toxicity of Eosinophil MBP Is Repressed by Intracellular Crystallization and Promoted by Extracellular Aggregation
Alice Soragni et al.
MOLECULAR CELL (2015)
Eosinophilia: a pragmatic approach to diagnosis and treatment
Amy D. Klion
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder
Paneez Khoury et al.
HAEMATOLOGICA (2015)
Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA
Irina Sadovnik et al.
EXPERIMENTAL HEMATOLOGY (2014)
Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity
Francis Davoine et al.
FRONTIERS IN IMMUNOLOGY (2014)
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field
Peter Valent et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
Eosinophils: multifaceted biological properties and roles in health and disease
Hirohito Kita
IMMUNOLOGICAL REVIEWS (2011)
Eosinophil extracellular DNA traps in skin diseases
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression
Sherry A. Hudson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-γ
Alexander M. de Bruin et al.
BLOOD (2010)
Churg-Strauss syndrome: evidence for disease subtypes?
Christian Pagnoux et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Refining the definition of hypereosinophilic syndrome
Hans-Uwe Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Practical approach to the patient with hypereosinophilia
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
What targeting eosinophils has taught us about their role in diseases
Bruce S. Bochner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
A novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome
S. Salemi et al.
ALLERGY (2009)
Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders
Peter Valent
BLOOD REVIEWS (2009)
Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology
Josiane S. Neves et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy
Princess U. Ogbogu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially
Lisa A. Spencer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Eosinophil-Selective Binding and Proapoptotic Effect in Vitro of a Synthetic Siglec-8 Ligand, Polymeric 6′-Sulfated Sialyl Lewis X
Sherry A. Hudson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome - a phase-II study
Georgia Metzgeroth et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Primary resistance to imatinib in Fip1-like1-platelet-derived growth factor receptor alpha - positive eosinophilic leukemia
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
J. Gotlib et al.
LEUKEMIA (2008)
Improvement of cardiac function, mitral regurgitation and pulmonary hypertension in a patient with chronic eosinophilic leukemia (CEL) after low dose imatinib therapy
Maria-Theresa Krauth et al.
LEUKEMIA RESEARCH (2008)
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense
Shida Yousefi et al.
NATURE MEDICINE (2008)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
Marc E. Rothenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Novel approaches to therapy of hypereosinophilic syndromes
Hans-Uwe Simon et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Lymphocytic variant hypereosinophilic syndromes
Florence Roufosse et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Evaluation and differential diagnosis of marked, persistent eosinophilia
Thomas B. Nutman
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome
Barbara J. Bain et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Eosinophilic disorders
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Inhibitory receptors on eosinophils: A direct hit to a possible Achilles heel?
Ariel Munitz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
Jelena V. Jovanovic et al.
BLOOD (2007)
Diagnostic and therapeutic management of eosinophilia-associated chronic myeloproliferative disorders
Andreas Reiter et al.
HAEMATOLOGICA (2007)
Churg-Strauss Syndrome
KA Keogh et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report
Amy D. Klion et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Hypereosinophilic syndrome: An update
HJ Wilkins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Interferon-gamma inhibits in vitro mobilization of eosinophils by interleukin-5
CS Park et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases
AE Kargili et al.
RHEUMATOLOGY INTERNATIONAL (2004)
Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes
JM Swartz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis
S Plotz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Expression and function of toll-like receptors in eosinophils: Activation by toll-like receptor 7 ligand
H Nagase et al.
JOURNAL OF IMMUNOLOGY (2003)
Changing expression of IL-3 and IL-5 receptors in cultured human eosinophils
C Yoshimura-Uchiyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome
HU Simon et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
J Cools et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils
O Noga et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers
A Menzies-Gow et al.
JOURNAL OF IMMUNOLOGY (2002)
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
JF Apperley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Human eosinophils express two Siglec-8 splice variants
H Aizawa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Churg-Strauss syndrome: update on recent developments
WL Gross
CURRENT OPINION IN RHEUMATOLOGY (2002)
Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment
BS Bochner et al.
IMMUNOLOGICAL REVIEWS (2001)
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration
JR White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome
F Roufosse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Mechanisms of eosinophil-associated inflammation
GJ Gleich
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
分享论文
